Cargando…
Retracted: Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307201/ https://www.ncbi.nlm.nih.gov/pubmed/37387970 http://dx.doi.org/10.1155/2023/9819628 |
Ejemplares similares
-
Retracted: Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: The Relationship between Ovarian Ultrasound Parameters and Endocrine and Metabolic Indicators in Patients with Ovarian Syndrome
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with EGFR-Mutated Non-Small-Cell Lung Cancer Regardless of Cerebrospinal Fluid T790M Mutational Status
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Analysis of the Efficacy of Multidrug Combination Chemotherapy Regimens for Osteosarcoma and the Management of Chemotherapeutic Reactions
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Continuity of Care plus Whole Process Psychological Intervention for Lung Cancer Patients undergoing Chemotherapy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)